Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19

"Federal budgetary institution of science Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protectionand Human Welfare", Moscow

"State Budgetary Institution of Healthcare of the City of Moscow City Polyclinic No. 2of the Department of Healthcare of the City of Moscow", Moscow

"Federal State Autonomous Educational Institution of Higher Education First MoscowState Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation", Moscow

"Private health care institution Clinical hospital 'Russian Railways - Medicine' of the city of Yaroslavl", Yaroslavl

"Limited Liability Company Research Center Eco-safety", Saint Petersburg

"Federal State Budgetary Institution Research Institute of Influenza named after A.A.Smorodintsev of the Ministry of Health of the Russian Federation", Saint Petersburg

"Municipal budgetary institution Central City Hospital No. 7", Yekaterinburg